Media advisory - Discovery at Shriners Hospitals for Children: Researchers find cause of painful bone disease

MONTREAL, Feb. 12, 2013 /CNW Telbec/ - Since the inception of its Research Department in 1972, Shriners Hospitals for Children®- Canada has garnered a world-wide reputation as a leader in the treatments of metabolic bone disorders. On February 12, principal investigators will present their latest discovery published in this month's American Journal of Human Genetics: Shriners Hospitals for Children®Canada is the first, worldwide, to identify the genetic defect underlying a painful bone disease called metaphyseal dysplasia with maxillary hypoplasia and brachydactyly or MDMHB. This disease causes an unusual series of symptoms including osteoporosis, severe tooth decay and spine fractures in teenagers.

During a Medical Round Table, media will have the opportunity to experience the scientific steps that led to the breakthrough and to interact with the two lead researchers behind this discovery: Frank Rauch, M.D., Director of Clinical Laboratories and Pierre Moffat, Ph. D., Investigator - both from Shriners Hospitals for Children - Canada.

When
Tuesday, February 12, 2013 at 9:30 a.m.

Where
Shriners Hospitals for Children-Canada
Conference Room
1529 Cedar Avenue
Montreal (Quebec)

RSVP
Emmanuelle Rondeau
Communications and Marketing Manager
Shriners Hospitals for Children®- Canada
Direct: 514-282-6990
Cell: 514-207-1057
erondeau@shrinenet.org

SOURCE: SHRINERS HOSPITAL FOR CHILDREN (CANADA)

For further information:

Emmanuelle Rondeau
Communications and Marketing Manager
Shriners Hospitals for Children®-Canada
Direct: 514-282-6990
Cell: 514-207-1057
erondeau@shrinenet.org